{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:51:53Z","timestamp":1788983513977,"version":"build-2803163510"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,1,15]]},"DOI":"10.2169\/internalmedicine.2963-19","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T22:20:27Z","timestamp":1579040427000},"page":"271-275","source":"Crossref","is-referenced-by-count":5,"title":["Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia"],"prefix":"10.2169","volume":"59","author":[{"given":"Xiaoling","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weihai Municipal Hospital, The Affiliated Hospital of Binzhou Medical College, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People's Hospital; Liaocheng Clinical School, Taishan Medical University, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Wang SJ, Zhao YY, Wang QZ, Guo B, Liu YM, Yan CZ. Pearls & Oy-sters: limbic encephalitis associated with positive anti-LGI1 and antithyroid antibodies. Neurology 86: e16-e18, 2016."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Kristinsson SY, Landgren O, Samuelsson J, Bjorkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95: 1216-1220, 2010.","DOI":"10.3324\/haematol.2009.020412"},{"key":"3","unstructured":"3. Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: documents summary and in-depth discussion. Blood Cancer J 8: 15, 2018."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127: 2391-2405, 2016.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dalmau J, Tuzun E, Wu HY. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36, 2007.","DOI":"10.1002\/ana.21050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257: 509-517, 2010.","DOI":"10.1007\/s00415-009-5431-9"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77: 179-189, 2011.","DOI":"10.1212\/WNL.0b013e318224afde"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Corsellis JA, Goldberg GJ, Norton AR.  "Limbic encephalitis" and its association with carcinoma. Brain 91: 481-496, 1968.","DOI":"10.1093\/brain\/91.3.481"},{"key":"9","unstructured":"9. Yuasa T, Fujita K. Limbic encephalitis--history, symptoms, and the latest classification. Brain Nerve 62: 817-826, 2010."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Graus F, Delattre JY, Antoine JC. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004.","DOI":"10.1136\/jnnp.2003.034447"},{"key":"11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.35.4.538","volume":"35","author":"F Graus","year":"1985","unstructured":"11. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35: 538-543, 1985.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"12","unstructured":"12. Shin YW, Lee ST, Shin JW, et al. VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 265: 75-81, 2013."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Alcantara M, Bennani O, Verdure P, Lepretre S, Tilly H, Jardin F. Voltage-gated potassium channel antibody paraneoplastic limbic encephalitis associated with acute myeloid leukemia. Case Rep Oncol 6: 289-292, 2013.","DOI":"10.1159\/000351835"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Blatt J, Greenwood R, Weig S, Rao K, Fedoriw GD, Dent G. Isolated central nervous system relapse in an adolescent with acute myelomonocytic leukemia, Charcot Marie Tooth syndrome, and paraneoplastic autoantibody. J Pediatr Hematol Oncol 32: 571-573, 2010.","DOI":"10.1097\/MPH.0b013e3181e92ae2"},{"key":"16","unstructured":"16. Kanemitsu M, Ueno H, Naito K. A case of paraneoplastic limbic encephalitis associated with malignant lymphoma presenting with a late-onset bilateral thalamic lesion. Brain Nerve 64: 71-77, 2012."},{"key":"17","unstructured":"17. Kawashima S, Okita K, Yamawaki T, Matsukawa N, Ojika K. Case of paraneoplastic limbic encephalitis associated with malignant B cell lymphoma. Brain Nerve 61: 208-212, 2009."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemiavera. Nature 434: 1144-1148, 2005.","DOI":"10.1038\/nature03546"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Baxter EJ, Scott LM, Campbell PJ, et al.; Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365: 1054-1061, 2005.","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352: 1779-1790, 2005.","DOI":"10.1056\/NEJMoa051113"},{"key":"21","unstructured":"21. Hasselbalch HC. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment? Leuk Res 33: 11-18, 2009."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sorensen AL, Hasselbalch HC. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Res 41: 27-35, 2016.","DOI":"10.1016\/j.leukres.2015.11.017"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Barbui T, Carobbio A, Finazzi G, et al. Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3. Haematologica 96: 315-318, 2011.","DOI":"10.3324\/haematol.2010.031070"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fleischman AG, Aichberger KJ, Luty SB, et al. TNF-alpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood 118: 6392-6398, 2011.","DOI":"10.1182\/blood-2011-04-348144"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/2\/59_2963-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T03:40:24Z","timestamp":1579318824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/2\/59_2963-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2963-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]}}}